Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) announced Wednesday that it has filed a prospectus supplement to register for resale 7,088,742 shares of its Class A common stock. The shares were issued ...
Google filed a patent titled ‘Ranking Search Results’ over a decade ago, outlining the use of branded search queries as a factor for ranking search results. The patent was widely misunderstood by the ...
Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...
Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
If you're looking for web links only in Google Search results, create a custom search shortcut for your browser. Peter is a writer and editor for the CNET How-To team. He has been covering technology, ...
Australia blew England away in the first Ashes Test to claim an eight-wicket victory inside two days at Perth Stadium. Following Ben Stokes’ bowling heroics on day one, England seemingly took control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback